(Q33732750)

29 July 2017

1 reference

title

Lassa fever: implications of T-cell immunity for vaccine development (English)

1 reference

29 July 2017

0 references

1 reference

ter Meulen J

1

1 reference

29 July 2017

publication date

1 August 1999

1 reference

29 July 2017

published in

Journal of Biotechnology

1 reference

29 July 2017

volume

73

1 reference

29 July 2017

issue

2-3

1 reference

29 July 2017

page(s)

207-212

1 reference

An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900122-4

7 January 2021

Current progress towards vaccines for arenavirus-caused diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900122-4

7 January 2021

Vaccination against persistent viral infection exacerbates CD4+ T-cell-mediated immunopathological disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900122-4

7 January 2021

Protection of Lassa virus-infected guinea pigs with Lassa-immune plasma of guinea pig, primate, and human origin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900122-4

7 January 2021

Serology and virulence diversity among Old-World arenaviruses, and the relevance to vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900122-4

7 January 2021

Endemic Lassa fever in Liberia. IV. Selection of optimally effective plasma for treatment by passive immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900122-4

7 January 2021

A non-retroviral RNA virus persists in DNA form

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900122-4

7 January 2021

A case-control study of the clinical diagnosis and course of Lassa fever

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900122-4

7 January 2021

Lassa fever--new issues raised by field studies in West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900122-4

7 January 2021

Vaccination for Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900122-4

7 January 2021

Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900122-4

7 January 2021

Specific cytotoxic T cells eliminate B cells producing virus-neutralizing antibodies [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900122-4

7 January 2021

Immunology taught by viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900122-4

7 January 2021

10.1016/S0168-1656(99)00122-4

Identifiers

DOI

1 reference

29 July 2017

1 reference